Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
Clinical trial NCT04176133 · COMPLETED
Trial details
- NCT number
- NCT04176133
- Sponsor
- Robert J. Pignolo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2022-03-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.